Recent developments to share with you

Congratulations! Our Company Won Third Prize in 2018 "Chuangye Jinling" Competition

2022-09-12

To implement the municipal party committee and municipal government's plan of building a globally influential innovation city, to create influential public platforms for technology services and innovation competitions, to discover and nurture outstanding innovation projects and entrepreneurial talents, and to promote and support technology startups, the Municipal Science and Technology Commission, together with relevant departments, organized the 2018 "Chuangye Jinling" Technology Innovation and Entrepreneurship Competition.

This year's competition followed the "121" innovation city strategy of the municipal party committee and government. Leveraging various districts and high-tech parks, the competition actively integrated and explored resources, attracting a total of 759 projects. Our company stood out with our project "Development of a Sustained-Release and Controlled-Release Generic and Improved Drug Technology Platform," achieving first place in the biomedical category and advancing to the finals, where we ultimately won third prize.

On August 18, the 2018 "Chuangye Jinling" awards ceremony was held at the Nanjing Broadcasting & Television Station. Leaders from the Municipal Publicity Department, Municipal Human Resources and Social Security Bureau, and Municipal Development and Reform Commission attended the ceremony and presented awards to the outstanding companies. Mr. Yin Laisheng, Chairman of our company, attended the ceremony on behalf of the company. Our company will next represent Nanjing in the 6th "Chuangye Jiangsu" Technology Innovation Competition. We wish our company continued success in the provincial competition!

Keywords：

Our Company Hires Professors in Pharmaceutics and Pharmaceutical Analysis from China Pharmaceutical University as Technical Advisors

Congratulations! Our Company Honored as "Excellent Enterprise" in the 2018 National Entrepreneurship Competition

Related information

Bountiful Results | January–July 2026: Kangchuanji Pharmaceutical, in collaboration with multiple pharmaceutical companies, secured approval or passed the evaluation for 15 product specifications.

From January to July 2026, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd., leveraging its deep-rooted pharmaceutical R&D expertise and mature end-to-end CDMO capabilities, has provided robust support for the innovative R&D and commercialization of its partner companies, achieving further regulatory‑review milestones in collaboration with multiple partners. According to the NMPA’s public announcement of drug approval documents, a total of 12 drug products (covering 15 specifications) have been successfully approved or passed consistency evaluation, demonstrating significant results in translating innovative research into tangible outcomes.

2026-08-04

CDE Announcement: Updated Guidelines for Pediatric Medicines! “Technical Guidance on the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Public Comment)”

On August 17, the CDE released a draft of the “Technical Guidance for the Application of Physiologically Based Pharmacokinetic Models in Pediatric Drug Development” for public comment.

2024-10-27

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03

Please contact us for more detailed information.

Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!

Nanjing Kangchuanji Pharmatech Co., Ltd.

Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

南京康川济医药科技有限公司

Recent developments to share with you

Congratulations! Our Company Won Third Prize in 2018 "Chuangye Jinling" Competition

COOKIES

COOKIES